| |
The epidermal gro wth factor (EGF ) receptor and its downstream signal transduction networks have been implicated in the ontology and maintenance of tumor tissues, which has motivated the discovery and development of molecularly targeted anti-EGF receptor therapies....
Editeur :
Humana
Parution :
2009-03-01
Collection :
Cancer Drug Discovery and Development
ePub
|
Supportive care of the cancer patient begins with the diagnosis of cancer and terminates with the end of life. The supportive care is for symptoms related to the cancer and/or its treatment; physical, psychosocial and emotional issues associated with the cancer....
Editeur :
Humana
Parution :
2009-01-07
Collection :
Cancer Drug Discovery and Development
ePub
|
Patients with cancer can suffer from a bewildering variety of neurologic signs and symptoms. The neurologic symptoms are often more disabling than the primary cancer. Symptoms including confusion, seizures, pain and paralysis may be a result of either metastases to the...
Editeur :
Oxford University Press
Parution :
2008-10-10
PDF
|
The number of factors implicated in the regulation of cell proliferation and differentiation is already considerable and more are continually being identified. This book concentrates on tumor necrosis factor (cachectin) and lymphotoxin, but includes observations of...
Editeur :
Wiley
Parution :
2008-04-30
Collection :
Novartis Foundation Symposia
PDF
|
This international symposium focuses on the contributions that biomedical research is making to the provision of proper health care for the increasing numbers of elderly people in all countries, developed and developing. Recent, encouraging developments in the areas of...
Editeur :
Wiley
Parution :
2008-04-30
Collection :
Novartis Foundation Symposia
PDF
|
This handbook is designed to help jobbing histopathologists jog their memory and get through more workload in any working day. Rapid access is facilitated by a bullet-point, tabular and diagrammatic style, as well as by handy anatomical diagrams, guidance on the...
Editeur :
Wiley
Parution :
2008-04-15
PDF, ePub
Offre spéciale
-9%
118,95€
|
This handbook is a practical and comprehensive introduction to the field of palliative medicine. It provides clear insight into many of the complex issues that arise in the delivery of palliative care and will be an invaluable resource to all disciplines involved in...
Editeur :
Wiley-Blackwell
Parution :
2008-04-15
PDF
|
This is a book about using the best evidence to inform treatment decisions for people with cancer. It is written by oncologists for oncologists, using examples throughout to illustrate key points. The book starts off with a "toolbox" section, written in a way which will...
Editeur :
BMJ Books
Parution :
2008-04-15
Collection :
Evidence-Based Medicine
PDF
|
Cancer Vaccines and Tumor Immunity offers a review of the basic scientific discoveries that have moved forward into clinical trials. Presented in the context of real-world human research and experimentation, these major scientific advances demonstrate how our...
Editeur :
Wiley-Liss
Parution :
2008-03-11
PDF
Offre spéciale
-10%
164,95€
|
|
|
The Advances in Cancer Research series provides invaluable information on the exciting and fast-moving field of cancer research. This volume presents outstanding and original reviews on a variety of topics including RUNX Genes in Development and Cancer;The RNA...
Editeur :
Academic Press
Parution :
2007-12-17
PDF, epub sans DRM
|
The World Health Organisation published 'Cancer Pain Relief' in 1990, advocating simplicity in the choice of analgesic and of route of administration. Since that time an increasing number of opioids for moderate to severe pain in an increasing number of formulations...
Editeur :
OUP Oxford
Parution :
2007-11-29
PDF
|
This second of two volumes on Cancer Imaging covers the three major topics of imaging instrumentation, general imaging applications, and imaging of a number of human cancer types. Where the first volume emphasized lung and breast carcinomas, Volume 2 focuses on...
Editeur :
Academic Press
Parution :
2007-11-21
epub sans DRM
|
Breast cancer is one of the leading causes of cancer mortality in women worldwide, and the risk of disease recurrence continues despite improvements in screening and treatment. For patients with hormone receptor-positive breast cancer, some form of endocrine therapy is...
Editeur :
OUP Oxford
Parution :
2007-11-08
PDF
|
Infections must be thought as one of the most important, if not the most important, risk factors for cancer development in humans. Approximately 15-20% of all cases of cancer around the world are caused by viruses. The establishment of a causal relationship between the...
Editeur :
Wiley-Blackwell
Parution :
2007-09-24
PDF
|
Without metastasis, prostate cancer would be both tolerable and treatable. The high incidence of indolent and organ confined disease is testament to this sweeping generalisation. Equally, if molecular markers of metastatic spread can be identified, then the choice of...
Editeur :
Springer
Parution :
2007-09-05
PDF
|
Cancer is a heterogeneous disease in most respects, including its cellularity, different genetic alterations and diverse clinical behaviors. Traditional molecular analyses are reductionist, assessing only one or a few genes at a time, thus working with a biologic model...
Editeur :
Springer
Parution :
2007-08-28
PDF
|
Radiation Oncology: A Physicist's-Eye View was written for both physicists and medical oncologists with the aim of helping them approach the use of radiation in the treatment of cancer with understanding, confidence, and imagination. The book will let...
Editeur :
Springer
Parution :
2007-08-14
Collection :
Biological and Medical Physics, Biomedical Engineering
PDF
|
Cancer stem cells werehave originally been identified in leukemia and later in several solid tumor types. They have very different properties from the bulk of the tumor, as they divide much more slowly and have very efficient drug- resistance mechanisms. Current...
Editeur :
Springer
Parution :
2007-08-03
PDF, ePub
|
ancer survivors have increased in number more than threefold over the last 30 years to the current level of 10 million and growing. Among patients diagnosed today, nearly Ctwo-thirds are expected to survive 5 or more years. This success may be attributed to the...
Editeur :
Springer
Parution :
2007-07-28
PDF
|